Effect of Endurance Training-Induced Coenzyme Q10 (CoQ10) Supplementation on Myokine, Exerkine Secretion and Cognitive Functions in Long-Distance Runners

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexMale
Age30-50
SponsorGdansk University of Physical Education and Sport

About this trial

The goal of this clinical trial is to learn if CoQ10 amplifies endurance training-induced myokine and exerkine secretion and if those changes influences cognition in long-distance runners.

Does 4-week high-dosage CoQ10 supplementation increase the secretion of myokine, exerkine sercetion? Does the above-mentioned intervention improve the cognitive function in long distance runners?

Participants will:

Take CoQ10 or a placebo every day for 4 weeks. Visit the laboratory once every 4 weeks for checkups and tests. Keep the participants' food and training diary.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

training experienced for minimum 2 years

running training at least 2 times per week

Personal Best on 10k (<50 minutes)

Disqualifiers

taking supplements which can interrupt primary outcomes (vitamin D, omega-3 fatty acids)

injured in last 6 months to avoid n number reduction

Trial design

Design model

Crossover

Treatments tested in this trial

  • CoQ10 supplementation

    Dietary supplement

    Long-distance runners will be supplemented with CoQ10 for 4 weeks in cross-over manner with 4 weeks of wash out period.

  • Placebo supplementation

    Dietary supplement

    Long-distance runners will be supplemented with placebo for 4 weeks in cross-over manner with 4 weeks of wash out period.

Treatment groups

24 Participants
are divided into 2 treatment groups
Group A: CoQ10-treated participantsExperimental treatment 1 intervention
Group B: Placebo-treated participantsPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in cognitive funtions as a result of CoQ10 supplementation measured via cogntitive function test.

The investigators assume that supplementation with CoQ10 will change cognition (measured via cognitive function tests - Stroop Test, Trial Making Test A and Trial Making Test B) in long-distance runners. The results will be obtained as time (seconds) needed to complete tasks while testing.

Time frame
The investigators are going to check this hypothesis after 4 weeks of high-dose supplementation with CoQ10
2

Change in myokine and exerkine concentration in the blood plasma as a result of CoQ10 supplementation.

The investigators will assess the concentration of blood myokine and exerkine concentration (pg or ug/dl) of blood plasma using the colorimetric method.

Time frame
The investigators are going to check this hypothesis after 4 weeks of high-dose supplementation with CoQ10

Secondary outcomes

1

Change in aerobic capacity measured via direct test to volitional exhaustion on a motorized treadmill

The investigators assume that supplementation with CoQ10 will change the aerobic capacity (oxygen uptake in ml-1 x min-1 x kg-1) in long-distance runners. The determination of aerobic capacity will be done through progressive test to volitional exhaustion on a motorized treadmill and gas analyzer

Time frame
The investigators are going to check this hypothesis after 4 weeks of high-dose supplementation with CoQ10

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.